Benjamin Dizier
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immunotherapy and Immune Responses 4
- Oncology 4
- Cancer Immunotherapy and Biomarkers 4
- Cytokine Signaling Pathways and Interactions 1
- Co-authors
- Bart Spiessens (4 shared papers)Fernando Ulloa‐Montoya (5 shared papers)Vincent Brichard (4 shared papers)Jamila Louahed (5 shared papers)Olivier Gruselle (3 shared papers)Johan Vansteenkiste (3 shared papers)Frédéric Lehmann (3 shared papers)Stefan Suciu (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)Journal of Clinical Oncology (1 paper)Biometrical Journal (1 paper)Annals of Oncology (1 paper)
- Partner nations
- BelgiumUnited StatesSwitzerland
In The Last Decade
Benjamin Dizier
7 papers receiving 370 citations
Peers
Comparison fields: 5 of 49
- Immunology 217
- Oncology 222
- Cancer Research 52
- Statistics and Probability 24
- Pulmonary and Respiratory Medicine 82
Countries citing papers authored by Benjamin Dizier
This map shows the geographic impact of Benjamin Dizier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Dizier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Dizier more than expected).
Fields of papers citing papers by Benjamin Dizier
This network shows the impact of papers produced by Benjamin Dizier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Dizier. The network helps show where Benjamin Dizier may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Dizier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 290 | |
| 2 | 2021 | 32 | |
| 3 | 2015 | 31 | |
| 4 | 2019 | 13 | |
| 5 | 2016 | 3 | |
| 6 | GENE EXPRESSION SIGNATURE IS A POTENTIAL PREDICTIVE FACTOR FOR EFFICACY OF MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT THERAPY IN RESECTED STAGE IB/II NON-SMALL CELL LUNG CANCER (NSCLC) | 2008 | 2 |
| 7 | Clinical Activity Following the Administration of the MAGE-A3 Antigen-specific Cancer Immunotherapeutic in Both the Melanoma and NSCLC is Associated With Similar Predictive Biomarkers Present Prior Treatment | 2009 | 2 |
| 8 | 2009 | 0 |
About Benjamin Dizier
Benjamin Dizier is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Statistics and Probability, having authored 8 papers that have together received 373 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), vaccines and immunoinformatics approaches (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Statistical Methods in Clinical Trials (2 papers), Cancer Genomics and Diagnostics (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Dermatology and Skin Diseases (1 paper). The work is most often cited by research in Immunology (217 citations), Oncology (222 citations), Cancer Research (52 citations), Statistics and Probability (24 citations) and Pulmonary and Respiratory Medicine (82 citations). Benjamin Dizier has collaborated with scholars based in Belgium, United States and Switzerland. Frequent co-authors include Bart Spiessens, Fernando Ulloa‐Montoya, Vincent Brichard, Jamila Louahed, Olivier Gruselle, Johan Vansteenkiste, Frédéric Lehmann, Stefan Suciu, Wim H.J. Kruit and Alexander M.M. Eggermont. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Journal of Clinical Oncology, Biometrical Journal and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.